139 Identifying neoantigens in lung adenocarcinoma patients

139 Identifying neoantigens in lung adenocarcinoma patients

Bibliographic Details
Main Authors:	Elizabeth Gensterblum-Miller, Qiao Li, Alfred E Chang, Ying Xin, Andrew C Chang, Assel Issabekova, Dyke McEwen, J Chad Brenner, Hannah Dobson
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Protecting Tumors by Preventing Human Papilloma Virus Antigen Presentation: Insights from Emerging Bioinformatics Algorithms
by: Elizabeth Gensterblum-Miller, et al.
Published: (2019-10-01)

Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma
by: Yukui Gao, et al.
Published: (2022-04-01)

1140 Labyrinthin as a potential neoantigen for oncogene-driven and non-oncogene-driven lung adenocarcinomas
by: Shuai Chen, et al.
Published: (2023-11-01)

Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction
by: Yueqiong Lao, et al.
Published: (2022-11-01)

Clinical heterogeneity in Fabry disease: A clinical case
by: Assel Issabekova, et al.
Published: (2023-08-01)

Lymphoma neoantigens
by: Joshua E. Elias
Published: (2018-06-01)

Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023-03-01)

327 Development and validation of a neoantigen-specific T cell gene signature to identify antitumor T cells in lung cancer and melanoma
by: Jiajia Zhang, et al.
Published: (2021-11-01)

Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
by: Melanie Boxberg, et al.
Published: (2021-09-01)

Salmo 139
by: Carlos Julián Reyes Toso
Published: (2022-11-01)

A139
by: O. Shpileva
Published: (2015-11-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
by: Zhenyu Ding, et al.
Published: (2021-01-01)

Immune determinants of Barrett’s progression to esophageal adenocarcinoma
by: Kiran H. Lagisetty, et al.
Published: (2021-01-01)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
by: Chang Yang, et al.
Published: (2021-06-01)

Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases
by: Xuesong Yang, et al.
Published: (2024-01-01)

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
by: Weijing Cai, et al.
Published: (2018-08-01)

Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
by: Meng Jia, et al.
Published: (2023-10-01)

Recent advances in neoantigen vaccines for treating non‐small cell lung cancer
by: Shu Su, et al.
Published: (2023-12-01)

Main Strategies for the Identification of Neoantigens
by: Alexander V. Gopanenko, et al.
Published: (2020-10-01)

The Neoantigen Landscape of Mycosis Fungoides
by: Arunima Sivanand, et al.
Published: (2020-11-01)

The Role of Neoantigens in Cancer Immunotherapy
by: Yueting Zhu, et al.
Published: (2021-08-01)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
by: Lijin Li, et al.
Published: (2021-04-01)

737 A novel humanized murine model to identify neoantigen-specific T cells in pediatric acute megakaryoblastic leukemia
by: Paul Thomas, et al.
Published: (2020-11-01)

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
by: Koji Nagaoka, et al.
Published: (2021-12-01)

Neoantigens in precision cancer immunotherapy: from identification to clinical applications
by: Qiao Zhang, et al.
Published: (2022-06-01)

P852: NEOANTIGENS PREDICTED BY THE GNE NEOANTIGEN PIPELINE IN PATIENTS DIAGNOSED WITH DE NOVO MULTIPLE MYELOMA
by: Y. Jiang, et al.
Published: (2022-06-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
by: Xizhe Li, et al.
Published: (2022-04-01)

Neoantigens: The Novel Precision Cancer Immunotherapy
by: Tiantian Zhang, et al.
Published: (2023-10-01)

The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023-08-01)

Mitochondrial Proteins as Source of Cancer Neoantigens
by: Gennaro Prota, et al.
Published: (2022-02-01)

Molecular mechanism of phosphopeptide neoantigen immunogenicity
by: Yury Patskovsky, et al.
Published: (2023-06-01)

Neoantigens: promising targets for cancer therapy
by: Na Xie, et al.
Published: (2023-01-01)

Structure Based Prediction of Neoantigen Immunogenicity
by: Timothy P. Riley, et al.
Published: (2019-08-01)

The Ways of Isolating Neoantigen-Specific T Cells
by: Qing Li, et al.
Published: (2020-08-01)

The Clinical Application of Neoantigens in Esophageal Cancer
by: Yi-Min Gu, et al.
Published: (2021-07-01)

Progress in Neoantigen Targeted Cancer Immunotherapies
by: Xue-Jiao Han, et al.
Published: (2020-07-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
by: Wang Wanqiu
Published: (2019-01-01)